Grasp the latest information from Olin and understand the new trends in the industry.
Recently, SSE, SZSE and SEHK simultaneously announced the inclusion of more listed companies’ stocks into the Underlying Stock List of Northbound Trading Link, marking a further expansion of the interoperability range of stock market trading between Chinese Mainland and Hong Kong...
On the afternoon of February 13, 2023, Mr. Rob Donelly, Commercial Minister of the Commercial Counsellor’s Office of the Australian Embassy in China and General Manager of Austrade Greater China, Mr. Rhett Miller, Deputy Consul General of the Australian Consulate General in Chengdu and Trade and Investment Commissioner of the Austrade...
Vaccines have played an irreplaceable role from vaccinia vaccination against smallpox in the 18th century in England to the national prevention and control of pandemic diseases typified by COVID-19 in the 21st century.
On July 6, 2022, Chengdu XENOMIX Biotechnology Co., Ltd. (hereinafter referred to as “XENOMIX”), a wholly-owned subsidiary of Chengdu Olymvax Biopharmaceuticals Inc., and Lanzhou Bailing Bio-Tech Company Limited (hereinafter referred to as “Bailing Bio-Tech”) held a signing ceremony for the cell-based influenza vaccine project in Chengdu.
On June 6, 2022, the Phase III Clinical Trial Kick-off Meeting of Recombinant Staphylococcus Aureus Vaccine (RSAV) (hereinafter referred to as “Staphylococcus Aureus Vaccine”), jointly developed by Chengdu Olymvax Biopharmaceuticals Inc.
On May 8, 2022, the “OLYMVAX Cup” the 8th CMC College Student’s “Internet +” Innovation and Entrepreneurship Competition, jointly organized by Chengdu Olymvax Biopharmaceuticals Inc.
On the morning of March 16, 2022, Ms. Adelle Neary, Consul General of Australian Consulate General in Chengdu, and her delegation visited OLYMVAX and discussed the future cooperation between the two parties.